SCHEMBL4904049

SCHEMBL4904049

Cc1ccc(S(=O)(=O)NCCc2ccc(NS(=O)(=O)c3ccc(C(F)(F)F)cc3)cc2)cc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.53
LMNA P02545 3/20 0.49
MAPT P10636 2/20 0.49
RECQL P46063 1/20 0.49
BRD4 O60885 1/20 0.48
PRMT1 Q99873 1/20 0.47
TP53 P04637 2/20 0.47
PTGDR2 Q9Y5Y4 1/20 0.47
SERPINE1 P05121 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895869 0.91 MAPK1 (0.49) POLBLMNAMAPTRECQLBRD4
SCHEMBL4904194 0.91 POLB (0.54) POLBLMNAMAPTRECQLPRMT1
SCHEMBL4903705 0.90 LMNA (0.53) LMNAMAPTRECQLTP53TDP1
SCHEMBL4903138 0.89 POLB (0.59) POLBLMNAMAPTRECQLPRMT1
SCHEMBL5368419 0.89 POLB (0.66) POLBMAPTBRD4HDAC3HDAC4
SCHEMBL4905434 0.89 MAPT (0.55) POLBLMNAMAPTRECQLPRMT1
SCHEMBL4894652 0.87 LMNA (0.50) POLBLMNAMAPTRECQLTP53
SCHEMBL4904125 0.87 LMNA (0.50) POLBLMNAMAPTRECQLTP53
SCHEMBL4905297 0.85 ADAMTS4 (0.50) POLBLMNATP53MAPK1PKM
SCHEMBL5373250 0.84 POLB (0.63) POLBMAPTBRD4KDM1AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885LMNA 319/4885MAPT 1786/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD POLB 1807/4885LMNA 319/4885MAPT 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.